Dianthus Therapeutics, Inc. (DNTH)
NASDAQ·Healthcare·Biotechnology
$107.00
+3.60%
Mkt Cap $6.05B
Analyst Ratings
Buy
5
Hold
0
Sell
0
Price Target (20 analysts)
$115.00
Range $55.00 – $145.00
Implied Upside
+7.5%
Consensus $115.00 vs current $107.00
NASDAQ·Healthcare·Biotechnology
$107.00
+3.60%
Mkt Cap $6.05B
Buy
5
Hold
0
Sell
0
Price Target (20 analysts)
$115.00
Range $55.00 – $145.00
+7.5%
Consensus $115.00 vs current $107.00